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BACKGROUND: Since the initial description of human
Tcell lymphotropic virus (HTLV-1), clusters of this infec-
tion have been detected globally. Unlike HIV infection,
most patients infected with HTLV-1 remain asymptom-
atic throughout their lifetime.
CASE REPORT: We report the case of a 39-year-old Afro-
Caribbean man with HTLV-1 infection presenting as
hypercalcemia and granulomatous pneumocystis jiro-
veci pneumonia.
RESULTS: Interestingly, the hypercalcemia presented
with normal parathyroid hormone–related protein and
low 1,25 dihydroxyvitamin D levels, and the presence of
pneumocystis jiroveci in the granulomas was diagnosed
with transbronchial biopsy taken during bronchoscopy.
HTLV-1-associated adult T cell leukemia lymphoma
(ATLL) was diagnosed in this patient by bone marrow
and lymph node biopsy.
CONCLUSION: Increased bone resorption, likely cyto-
kine-mediated, is the most likely mechanism of hyper-
calcemia in this patient. This is believed to be the first
description of this type of reaction to pneumocystis
jiroveci in a HTLV-1-infected ATLL patient.
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INTRODUCTION
Since the initial description of human T cell lymphotropic virus
(HTLV-1), clusters of this infection have been detected in Japan
(seroprevalence 1–20%), the Caribbean, the Southwestern
United States, Sub-Saharan Africa, Iran, and Europe.
1,3–8
Unlike HIVinfection, most patients infected with HTLV-1 remain
asymptomatic throughout their lifetime.
1,7 Adult T Cell leukemia
lymphoma (ATLL) is a clinical manifestation of HTLV-1 infection.
In addition, HTLV-1 is an etiologic agent for a progressive
neurological disease called HTLV-1-associated myelopathy/
tropical spastic paraparesis.
9
Hypercalcemia may be associated with HTLV-1 infec-
tion,
7,8,10–15 where increased bone resorption mediated by
parathyroid hormone–related protein (PTHrP)
1,3,7,8,10–15 or
lymphokines
10,11 has been implicated.
Ninety percent of patients with ATLL suffer from life-threat-
ening pulmonary complications,
1,2 including opportunistic
lung infections such as pneumocystis jiroveci pneumonia
(PJP).
1,2,4,16 Although prior reports of granulomatous PJP have
been described in HIV-negative patients with malignancy
17,18,19
or in patients receiving immunosuppressive treatment,
20,22–25
this pathologic manifestation of pneumocystis jiroveci has not
been previously reported in HTLV-1 infection.
We report a case of HTLV-1 infection with granulomatous
PJP on lung biopsy with a normal CD4 count and hypercalce-
mia with normal serum PTHrP and low 1,25 dihydroxyvitamin
D (1,25(OH)2D) levels. We believe that increased bone resorp-
tion, probably cytokine-mediated, is the most likely mecha-
nism of hypercalcemia in this patient.
CASE REPORT
A 39-year-old Afro-Caribbean man, with no significant medical
history, presented to Queens Hospital Center in March 2004
with complaints of weight loss, generalized weakness, and joint
pain associated with decreased exercise tolerance for 3 weeks.
The patient denied taking any medications, including over-the-
counter preparations.
The physical examination was remarkable for a low-grade
temperature of 99.2°F and for bilateral palpable, nontender,
mobile axillary, and inguinal lymph nodes. The lungs were clear.
Neurologically, the patient was alert and oriented to person, place,
and time without any focal deficits. Strength testing revealed full
p o w e rb i l a t e r a l l yi nb o t ht h eu p p e ra n dl o w e re x t r e m i t i e s .
Laboratory values were notable for a white blood cell count
of 11,700/mm
3 and a hematocrit of 29.4%. Serum chemistry
profile (see Table 1) was remarkable for sodium of 131 mEq/L,
blood urea nitrogen 39 mg/dL, creatinine 3.5 mg/dL, calcium
17.2 mg/dL (8.5–10.5 mg/dL), serum albumin 2.7 g/dL,
corrected serum calcium 18.2 mg/dL, and phosphate
2.5 mg/dL (2.5–4.9 mg/dL). The work-up for hypercalcemia
revealed an intact parathyroid hormone level of 7.6 pg/mL (12–
72), a PTHrP level of <0.7 pmol/L (<1.3), 1,25(OH)2D level of
46 pg/mL (19–67), and an angiotensin-converting enzyme level
of 61 U/L (67–99). A repeat serum 1,25(OH)2D level was 5 pg/mL.
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420Serum and urine protein electrophoreses were normal. Antibodies
to HTLV-I/II tested positive. The CD4 helper T cell count was
1,717/mm
3 (515–1,595), the CD8 suppressor T cell count was
530/mm
3 (237–928), and the CD4/CD8 ratio was 3.24 (0.90–
2.90). Antibodies to HIV were negative. The peripheral blood
smear showed atypical lymphocytes with irregular nuclear
borders described as “clover leaf.”
A bone marrow biopsy revealed atypical lymphocyte infiltra-
tion. Flow cytometry of the bone marrow biopsy revealed that
the majority of cells were immunoreactive for CD45, CD2,
CD3, CD4, and CD30, whereas the expression of CD5 and CD7
was greatly reduced compared to CD2 and CD3. CD8 positive
cells were only rudimentarily present. The strong presence of
CD2, CD3, and CD4 coupled with the much weaker immuno-
reactivity of CD7 and CD8 was consistent with a diagnosis of
ATLL. An axillary lymph node biopsy was also consistent with
the diagnosis of ATLL.
Chest roentgenogram revealed fine diffuse reticulonodular
densities, which were confirmed with a computed tomography
scan of the thorax. Bilateral axillary node enlargement was
also demonstrated. A skeletal survey revealed osteoporosis of
the peripheral skeleton.
The patient underwent bronchoscopy with left lower lobe
transbronchial biopsy, which revealed lung parenchyma with
necrotizing and nonnecrotizing granulomas that stained pos-
itive for pneumocystis jiroveci (Gomori methenamine silver
stain) and negative for acid-fast bacilli. Bronchoalveolar lavage
fluid showed a CD4 helper T cell count of 60 U and CD8
suppressor T cell count of 37 U, with a normal CD4/CD8 ratio
of 1.62. Neither acid-fast bacilli nor pneumocystis jiroveci
organisms were present in the bronchoalveolar lavage fluid.
The hypercalcemia was treated with intravenous (IV) hydra-
tion, furosemide, pamidronate, and calcitonin. With hydration
alone (using IV normal saline), the corrected serum calcium
dropped by 2 mg/dL over the first 24 hours. Ninety milligrams
of IV pamidronate was subsequently started, and the corrected
serum calcium dropped an additional 2 mg/dL to 14.7 mg/dL
over the next 2 days (see Table 1). At this point, the serum
creatinine had dropped from 3.5 to 2.3 mg/dL. Intravenous
hydration was continued and an additional dose of 60 mg of IV
pamidronate was given 6 days after the first dose, with a
further reduction in serum calcium level. Eleven days after
admission, the corrected serum calcium level had dropped to
12.5 mg/dL and the serum creatinine was 1.8 mg/dL. The
patient’s symptoms improved. Treatment for PJP was started.
Of note, when prednisone 40 mg daily was added there was no
further decrease in the patient’s serum calcium level (see
Table 1). The hyponatremia seen on admission (131 mEq/L)
corrected to near normal levels after a day of IV hydration,
suggesting the etiology of the hyponatremia was dehydration.
The admission course was complicated by a displaced fracture
of the right patella that occurred while the patient was
walking.
DISCUSSION
ATLL, a malignancy of helper/inducer T lymphocytes, is
associated with HTLV-1 infection. Clinically, ATLL may present
as leukemia, lymphoma, hypercalcemia, tumor infiltrates of
the skin or lungs, hepatosplenomegaly and lytic bone
lesions.
1,2 Most patients studied with HTLV-1-associated T cell
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421 Shahnaz et al.: HTLV-1-Associated ATLL Presenting as Granulomatous PJP JGIMlymphomas have developed a syndrome of increased bone
turnover and hypercalcemia at some time during the course of
the disease.
1–3,5,7,8
The mechanism for hypercalcemia has been described as
increased bone resorption mediated by PTHrP or lymphokines,
such as interleukin 1 (IL-1), IL-2, IL-6, and tumor necrosis
factor (TNF).
10,12 Although the PTHrP level was not elevated in
our patient, and IL levels were not measured, the mechanism
for hypercalcemia was very likely increased bone resorption as
evidenced by the rapid response to IV pamidronate. Although
this patient did not have a bone density test to formally
diagnose osteoporosis, the occurrence of the pathological
fracture of the right patella may be because of this state of
increased bone resorption. The high normal level of serum
alkaline phosphatase (see Table 1) suggests that increased
resorption of bone was taking place.
Although hypercalcemia has been reported in PJP, the
underlying mechanism described is increased 1,25(OH)2D
production by the granulomatous tissue,
24,25 and this level
was low in our patient, indicating that PJP was not the cause
of hypercalcemia in this patient. Furthermore, the relatively
low serum phosphorus level and the lack of response to pre-
dnisone in terms of a lowering of serum calcium both argue
against excess 1,25(OH)2D as the etiology of the hypercalcemia.
ATLL, the aggressive form of HTLV-1 infection, has long been
recognized as a cause of immunosuppression and opportunis-
tic infections, including PJP.
16 In contrast to HIV infection,
where CD4 counts can be used as a measure of immune
deficiency because of profound depletion in the number and
function of these cells, HTLV-1 infection and ATLL are charac-
terized by proliferation of dysfunctional CD4 cells.
4–7 Only a
few reports of pneumocystis jiroveci infection have been re-
ported in HTLV-1 carriers, and none of them have presented as
granulomatous inflammation.
Granulomatous PJP has rarely been described in patients
with malignancy and immunosuppression because of chemo-
therapy or high-dose corticosteroids.
17,19,26 This pathological
reaction poses a diagnostic challenge, as it mimics other granu-
lomatous diseases.
17,18,21 The development of granulomatous
PJP in our patient with HTLV-1 infection and a normal CD4
count may be related to partial immunosuppression with
preservation of immune cell number and adequate production
of IL-2, interferon gamma, and TNF alpha, all crucial factors in
granuloma formation.
This is the first case reported in the literature of granulo-
matous PJP occurring in a patient infected with HTLV-1. There
is not a lot of information in the literature concerning the
typical presentations of PJP in patients who have HTLV-1.
There are, however, two relevant case reports. In one report a
patient had patchy, nonsegmented bilateral infiltrates.
27 In
another patient, there was a diagnosis of pneumonia caused
by PJP, mycoplasma, mycobacterium avium-intracellulare,
and cryptococcus. The presentation was lobar infiltrates,
pleural effusion, patchy alveolar infiltrates, and mediastinal
adenopathy.
4 Interestingly, the hypercalcemia in our patient
occurred in the setting of normal PTHrP and low 1,25(OH)2D
levels, supporting the role for cytokines in the development of
HTLV-1-related hypercalcemia. Specific cytokines were not
measured on this patient, and this may represent a limitation
of our paper. The possibility of PTHrP acting as a cytokine,
causing bone destruction and hypercalcemia, even with normal
serum levels of PTHrP, has been described in breast cancer.
28
Whether this phenomenon can occur in HTLV-1-associated
hypercalcemia is not known.
This case reminds us that patients with HTLV-1 infection
may have many reasons to present with hypercalcemia. We
believe the reason for the hypercalcemia in our patient was
increased bone resorption.
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